Clinical Hematology and Research

Editorial Board


Prof. William Tse

Professor
James Graham Brown Cancer Center
University of Louisville
Louisville, United States of America
Tel: 502-681-1359


Dr. William Tse is Professor of Medicine at James Graham Brown Cancer Center, University of Louisville School of Medicine. Dr. Tse received his medical degree from Sun Yat-Sen University School of Medicine, Guangzhou, P. R. China. He completed his internal medicine

Dr. William Tse is Professor of Medicine at James Graham Brown Cancer Center, University of Louisville School of Medicine. Dr. Tse received his medical degree from Sun Yat-Sen University School of Medicine, Guangzhou, P. R. China. He completed his internal medicine training at Long Island Jewish Medical Center/Albert Einstein College of Medicine and Medical Oncology/Bone Marrow Transplantation Fellowship at The Fred Hutchinson Cancer Research Center/University of Washington School of Medicine. Along with his clinical training, he received his laboratory research training at the Ontario Cancer Institute/Princess Margaret Hospital and The Hospital for Sick Children, University of Toronto, Toronto, Canada. He received the National Cancer Institute of Canada's Terry Fox Physician Scientist Fellowship Award, the Association of Specialty Professors (ASP) T. Franklin Williams Scholar Award, and the ASCO Career Development Award. Other honors that he has received include the Dr. Irwin Katzka Memorial Award for Humanitarianism and Resident Teacher of the Year from Long Island Jewish Medical Center, Albert Einstein College of Medicine at Long Island Campus. Dr. Tse's research is focused on clinical and translational cancer research for hematopoietic malignancies including pre-clinical models for developmental therapeutics, cancer biology, and cancer cell signaling network profiles. Dr. Tse's work demonstrates an innovative multi-targeted therapeutic approach for a subgroup of leukemia and solid cancer patients that have the AF1q-centered aberrant signaling pathways.
Dr. Tamar Ben Yedidia

Chief Scientific Officer
BiondVax Pharmaceuticals
Weizmann Science Park
Israel
Tel: +97289302529


Dr. Tamar Ben-Yedidia has more than 15 years of experience in the field of Immunology, with specific expertise in the development of vaccines. She started her career with Biotechnology General Ltd, BTG (Rehovot), working on the development of a recombinant Hepatitis-B

Dr. Tamar Ben-Yedidia has more than 15 years of experience in the field of Immunology, with specific expertise in the development of vaccines. She started her career with Biotechnology General Ltd, BTG (Rehovot), working on the development of a recombinant Hepatitis-B vaccine.She joined the Weizmann Institute of Science in 1994, and under the auspices of Prof. Ruth Arnon in the Department of Immunology, worked on the design of a peptide-based vaccine against several pathogens and focused on influenza. She continued this work when she left the Weizmann Institute in 2004 to join BiondVax.Dr. Ben-Yedidia was involved in two European Consortium projects related to evaluation of different approaches for vaccination in which leading laboratories in the field participated. Dr. Ben-Yedidia is often invited to address conferences around the world and is widely published, with numerous refereed articles and invited reviews in various renowned scientific journals.Dr. Ben-Yedidia received her Ph.D. from the Weizmann Institute after completion of her doctoral thesis entitled “A Peptide-Based Vaccine Against Influenza”.
Dr. Nagahito Saito

Hematological clinician
Hematological section
Takagi hospital
Saga city
Japan


Dr. Nagahito Saito have made the research in the laboratories of both Hokkaido University Graduate School of Medicine and Asahikawa Medical University School of Medicine in Japan providing medical care of the patients with several blood diseases. He have specialized

Dr. Nagahito Saito have made the research in the laboratories of both Hokkaido University Graduate School of Medicine and Asahikawa Medical University School of Medicine in Japan providing medical care of the patients with several blood diseases. He have specialized in the study of blood morphology by light and electron microscopy. He have applied both histochemical and silver enhancing immunogold method for light microscopy and both the histochemical and immunogold method in addition to the scanning electron microscopical one as ultra structural techniques. He began to research H.pylori which is known to make gastric carcinoma, MALToma and so on. I have morphological observed the nature and function of H.pylori adding to those of blood cells using ultra structural methods.
Dr. Mark Joseph Fesler

Director
Blood and Marrow Transplant Program
Saint Louis University
United States of America
Tel: 314-577-6057


Dr. Mark J Fesler is the Director of the Blood and Marrow Transplant Program at Saint Louis University Hospital. Dr. Fesler earned a medical degree from Saint Louis University School of Medicine, followed by internal medicine residency at the University of

Dr. Mark J Fesler is the Director of the Blood and Marrow Transplant Program at Saint Louis University Hospital. Dr. Fesler earned a medical degree from Saint Louis University School of Medicine, followed by internal medicine residency at the University of Colorado Health Sciences Center, where he was chief resident his final year. He completed a fellowship in hematology and oncology at Saint Louis University School of Medicine and is board-certified in both hematology and medical oncology. He is a member of the American Society of Hematology and the American Society of Clinical Oncology. He has received numerous honors and awards including the SLUCare Caring Physician Award, the Tenet Hospital Service Excellence Award, a Faculty Career Development Award, and a SLUCor Research Development Award. He is the author of numerous abstracts and publications and an accomplished lecturer in topics related to hematologic malignancy. Dr. Fesler's research interests include non Hodgkin and Hodgkin lymphoma.
Prof. James CS Chim

Endowed Professor
Department Haematology & Oncology
Queen Mary Hospital
University of Hong Kong
Hong Kong


Prof. James CS Chim is SH Ho Professor of Haematology and Medical Oncology, Queen Mary Hospital, University of Hong Kong, Hong Kong. Prof.Chim is a clinician scientist & double fellow of both the Royal Colleges of Physicians and Pathologists of UK.

Prof. James CS Chim is SH Ho Professor of Haematology and Medical Oncology, Queen Mary Hospital, University of Hong Kong, Hong Kong. Prof.Chim is a clinician scientist & double fellow of both the Royal Colleges of Physicians and Pathologists of UK. He has published more than 230 papers in peer-reviewed journals. Prof.Chim is a Member of the International Myeloma Working Group (IMWG), Executive Committee member of Asia Myeloma Network, Chairman of Education Program, Asia Pacific Hematology Consortium (APHCON), the Founding Chairman of the Hong Kong Society of Myeloma. He is on the editorial board of multiple journals. He has been invited reviewer for American Society of Hematology (ASH) and external reviewer for prestigious grant funding organizations including Leukaemia & Lymphoma Research, Leukemia Research (United Kingdom), Cancer Research United Kingdom, The Agency for Science, Technology and Research of Singapore and Association for International Cancer Research (AICR). Prof. Chim was awarded the State Scientific and Technological Progress Award in 2009, and is currently Visiting Professor to 10 universities in mainland China. Prof. Chim's research interests include Epigenetic alterations in hematological malignancies, DNA methylation, Clinical trials in multiple myeloma, lymphoma and leukemia.
Prof. Roganovic Jelena

Professor of Pediatrics
Head of Hematology and Oncology Division
Clinical Hospital Center Rijeka
University of Rijeka
Croatia


Dr. Roganovic Jelena is the Full Professor of Pediatrics, School of Medicine Rijeka, and the Head of the Division of Hematology and Oncology, Department of Pediatrics, Clinical Hospital Centre Rijeka. Dr. Roganovic received her M.D. and Ph.D. from Rijeka University School

Dr. Roganovic Jelena is the Full Professor of Pediatrics, School of Medicine Rijeka, and the Head of the Division of Hematology and Oncology, Department of Pediatrics, Clinical Hospital Centre Rijeka. Dr. Roganovic received her M.D. and Ph.D. from Rijeka University School of Medicine, Croatia. She completed her medical education from Rijeka/Croatia, Padua/Italy, and Cincinnati/USA. Dr Roganovic is a certified member of many national and international pediatric Hematological and oncological societies. She published more than 300 papers, book chapters, proceedings and abstracts. She received many awards, the most recent being University of Rijeka Foundation Award for the contribution in "Biomedical and biotechnical sciences 2013". She is a certified member of many national and international pediatric societies, taking an active and remarkable contribution in several European boards/committees. She serves as a reviewer for a number of national and international journals, and is an editorial board member of several journal of international repute. Dr. Roganovic's research interests include Pediatric oncology and hematology; leukemia, lymphoma, solid tumors; late effects of the treatment of childhood cancer; immune thrombocytopenia, rare anemias.
Dr. Ken He Young

Associate Professor
Department of Hematopathology
The University of Texas MD Anderson Cancer Center
Texas, United States of America
Tel: 713-745-2598


Dr. Ken He Young is an Associate Professor of Hematopathology Department at The University of Texas MD Anderson Cancer Center, Texas, USA. Dr. Ken received his MD (1984) from Zhejiang University School of Medicine, China and PhD (1995) from University

Dr. Ken He Young is an Associate Professor of Hematopathology Department at The University of Texas MD Anderson Cancer Center, Texas, USA. Dr. Ken received his MD (1984) from Zhejiang University School of Medicine, China and PhD (1995) from University of Lund School of Medicine, Sweden. Research in his team includes several types of hematologic malignancies, with special emphasis on pathogenesis of malignant lymphomas, especially diffuse large B-cell lymphoma (DLBCL). The goal of Dr. Ken's team is to explore and identify genetic and non-genetic biomarkers, including p53, Myc, pTEN, Mdm2, Arf, Bcl-2, Bcl-6 genes, alone or in combination with other abnormalities in DLBCL, that predict cancer prognosis and susceptibility. Dr. Ken's primary study of genomic alterations is on TP53 tumor suppressor pathway and secondary focus is on Myc oncogene.
Prof. Chao Hung Ho

Professor
Division of Haematology
Conde S Januario General Hospital
China
Tel: 853-63009139


Prof. Chao-Hung Ho is working as Professor/chief doctor in Division of Haematology at Conde S Januario General Hospital, Macau, China. He worked as Professor in College of Medicine & Health Sciences, Oman and National Yang Ming University (NYMU),Taiwan. Prof. Ho received

Prof. Chao-Hung Ho is working as Professor/chief doctor in Division of Haematology at Conde S Januario General Hospital, Macau, China. He worked as Professor in College of Medicine & Health Sciences, Oman and National Yang Ming University (NYMU),Taiwan. Prof. Ho received his Bachelor Degree of Medicine from National Defense Medical Center, Taiwan and Obtained the Medical License of Hong Kong from The Medical Council Committee of Hong Kong. he then worked as Chief Resident doctor of the Hematology Section in Taipei Veterans General Hospital, Taiwan. His research interests include von Willebrand disease, Anemia, Hemostasis thrombophilia, leukemia, lymphoma, multiple myeloma, myeloproliferative disorder, etc.